Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
Market Cap
$3.50M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.52
3Y Avg
0.43
5Y Avg
0.47
Market Cap
$3.49M
Quick Ratio (Acid-Test)
1.97
TTM Avg
1.45
3Y Avg
2.21
5Y Avg
4.94
Market Cap
$3.53M
Quick Ratio (Acid-Test)
3.73
TTM Avg
3.25
3Y Avg
4.33
5Y Avg
4.33
Market Cap
$3.63M
Quick Ratio (Acid-Test)
0.82
TTM Avg
1.40
3Y Avg
1.07
5Y Avg
0.94
Market Cap
$3.65M
Quick Ratio (Acid-Test)
2.01
TTM Avg
0.91
3Y Avg
1.26
5Y Avg
1.78
Market Cap
$3.30M
Quick Ratio (Acid-Test)
1.10
TTM Avg
5.81
3Y Avg
5.76
5Y Avg
3.90
Market Cap
$3.28M
Quick Ratio (Acid-Test)
8.13
TTM Avg
4.58
3Y Avg
2.68
5Y Avg
3.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.50M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.50M | 0.08 | 0.52 | 0.43 | 0.47 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 1.97 | 1.45 | 2.21 | 4.94 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 3.73 | 3.25 | 4.33 | 4.33 |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | 0.82 | 1.40 | 1.07 | 0.94 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | 2.01 | 0.91 | 1.26 | 1.78 |
| Evogene Ltd. (EVGN)vs › | $3.65M | 3.54 | 2.77 | 4.28 | 5.12 |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 1.10 | 5.81 | 5.76 | 3.90 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | 8.13 | 4.58 | 2.68 | 3.19 |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.05 | 0.10 | 7.85 | 8.89 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
